Discontinued — last reported Q2 '22
Thermo Fisher Scientific Deferred Taxes increased by 85.6% to -$127.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 131.8%, from $400.00M to -$127.00M. Over 3 years (FY 2021 to FY 2024), Deferred Taxes shows an upward trend with a 23.2% CAGR.
Significant changes can indicate shifts in tax strategy, capital investment timing, or changes in accounting estimates.
Deferred income taxes represent the temporary differences between the tax expense reported on the income statement and t...
Standard line item for all large corporations subject to complex tax jurisdictions.
cf_deferred_income_taxes| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $331.00M | $148.00M | $192.00M | $339.00M | $262.00M | $261.00M | $133.00M | $146.00M | $182.00M | $303.00M | $669.00M | $253.00M | $354.00M | $400.00M | $202.00M | $279.00M | -$880.00M | -$127.00M |
| QoQ Change | — | -55.3% | +29.7% | +76.6% | -22.7% | -0.4% | -49.0% | +9.8% | +24.7% | +66.5% | +120.8% | -62.2% | +39.9% | +13.0% | -49.5% | +38.1% | -415.4% | +85.6% |
| YoY Change | — | — | — | — | -20.8% | +76.4% | -30.7% | -56.9% | -30.5% | +16.1% | +403.0% | +73.3% | +94.5% | +32.0% | -69.8% | +10.3% | -348.6% | -131.8% |
We use cookies for analytics. See our Privacy and Cookie Policy.